Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Insight into Cancer Vaccines

Using Biomarkers to Detect Cancer

Overview of Cell Viability and Cytotoxicity

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What is Merkel Cell Carcinoma?

What is Cancer?

Cancer Prevention: Lowering your Risk

Why are Cancer Cell Lines Useful?

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

British Pioneers in Cancer Biology

Cancer History

See more featured articles »

Cancer Pain

Cancer Classification

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Research

Secondary Lung Cancer

What is the Tumor Microenvironment?

Cancer Management

Cancer Screening Considerations: Balancing the Benefits and Risks

Acidosis and Tumor Progression

The Biochemistry of Breast Cancer Screening

Exploiting Enzymes in Cancer Diagnosis and Therapy

What is Immunochemotherapy?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is Cancer of Unknown Primary?

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Diagnosis

Caring for a Loved One with Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pathophysiology

Myc Mutations and Cancer

Cancer Glossary

Investigating the Molecular Mechanisms of Cancer

Living with Cancer Pain

The Effects of Cancer on Family Life

What Causes Cancer?

Cutaneous Manifestations of Internal Malignancy

Metastatic Migration in Cancer may be Influenced by Metabolism

Hypoxia Markers and Their Importance

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Hot vs Cold: the differences between tumor types

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Symptoms

Secondary Brain Cancer

Is Cancer a Metabolic Disorder?

What is Tumorigenesis?

Cancer Prognosis

Transforming Cancer Care through Genomic Testing

Effects of Social and Economic Deprivation on Cancer Mortality

Pediatric Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Pain Management

The Cancer Cell Surface Proteome as a Therapeutic Target

What Role do Biobanks Play in Cancer Research?

Insights into Oncofertility

Cancer Epidemiology

TARDIS: The Improved Method of Detecting Breast Cancer

Targeted Cancer Therapies

CDK9 and Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Latest Cancer News and Research

Mesothelial cells enable rapid invasion and spread of ovarian cancer

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen.

7 Feb 2026

Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity

In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular "brakes" on T cells.

7 Feb 2026

Tumor-targeted chimeric drug increases efficacy and limits side effects

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively.

7 Feb 2026

American women show varied preferences for in-clinic versus at-home cervical cancer screening

American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools.

7 Feb 2026

Water pressure mechanism enables fast amoeboid cancer cell movement

Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells.

7 Feb 2026

RNA micelles enable targeted chemotherapy without immune toxicity

A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or toxicity-related side effects.

7 Feb 2026

New analysis reveals hidden complexity in the vaginal microbiome

For decades, gynecological tests have relied on a simplified view of the vaginal microbiome, categorizing bacteria as either "good" or "bad."

6 Feb 2026

Senescent neutrophils promote tumor survival across cancer types

Renowned as first responders to threatening infections, neutrophils also happen to feature prominently in the microenvironment of tumors, where they and other immune cells play opposing and frequently mutable roles in promoting-or resisting-cancer progression.

6 Feb 2026

European collaboration transforms immune cell data into cancer biomarkers

World Cancer Day, marked on 4 February, is an international day dedicated to raising awareness of cancer, and to encouraging its prevention, detection and treatment.

6 Feb 2026

Triple negative breast cancer cells use new strategy to boost metastatic ability

Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.

6 Feb 2026

11th Innate Killer Summit returns to San Diego, showcasing clinical data that signals renewed momentum in NK cell therapy

The 11th Innate Killer Summit returns, bringing together global leaders advancing natural killer (NK) cell–based immunotherapies.

From Hanson Wade Group - 11th Innate Killer Summit 6 Feb 2026

Early biomarkers predict infections after breast reconstruction surgery

In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies.

5 Feb 2026

Computational method clarifies microbial signals in tumor sequencing

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how they grow, evade immunity or respond to treatment.

5 Feb 2026

Large trials show statins rarely cause reported side effects

Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.

5 Feb 2026

Ulcerative proctitis not linked to increased rectal cancer risk

People with ulcerative proctitis, a milder and more limited form of ulcerative colitis, are not at higher risk of developing rectal cancer than the general population.

5 Feb 2026

Enhanced natural killer cells show promise for HIV remission

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).

5 Feb 2026

New report highlights a rare case of 5-fluorouracil-induced hyperammonemic encephalopathy

A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled "Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy."

5 Feb 2026

Reprogrammed neutrophils promote tumor growth

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, undergo reprogramming when they come into contact with the tumor ecosystem and contribute to its progression.

5 Feb 2026

AI foundation model advances comprehensive brain MRI analysis

Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, predicting dementia risk, detecting brain tumor mutations and predicting brain cancer survival.

5 Feb 2026

Gut microbial butyrate enhances mucosal vaccine antibody responses

A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing how butyrate-a short-chain fatty acid produced by gut commensal bacteria-enhances T follicular helper (Tfh) cell activity to promote antibody production and strengthen mucosal vaccine efficacy.

4 Feb 2026